Name (Synonyms) | Correlation | |
---|---|---|
drug2209 | Pozelimab Wiki | 1.00 |
drug1835 | Nasal swab Wiki | 0.71 |
Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This study is a case-control study to characterize the molecular and cellular anomalies of the olfactory epithelium of COVID-19 patients with isolated anosmia, by comparison with the olfactory epithelium of non-infected subjects.
Description: Ratio of olfactory sensory cells in the nasal cytological sample
Measure: Molecular and cellular defects in olfactory epithelium Time: 30 monthsDescription: Multiple measurements will be analyzed to characterize the immune and inflamatory status of the olfactory mucosa (presence of infiltrated immune cells, activation state of the immune cells in the epithelium, cytokine and interleukin level)
Measure: Biological mechanisms involved in the pathogenesis of the disease Time: 30 monthsDescription: Demographic variables (sex, age, blood type), risk factors (tobacco, overweight, diabetes, rhinosinusitis disease, respiratory allergy)
Measure: Epidemiological characteristics Time: 30 monthsDescription: Self-questionnaire taste and smell survey (TTS)
Measure: Olfactory and taste dysfunction Time: 30 monthsDescription: Visual analogue scale (VAS) (units from 0 normal perception to 100 no perception)
Measure: Olfactory and taste dysfunction Time: 30 months